BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9789868)

  • 1. In vitro activity of sertaconazole against Malassezia furfur and pachydermatis in different culture media.
    Palacin C; Tarragó C; Ortiz JA
    Methods Find Exp Clin Pharmacol; 1998; 20(6):451-5. PubMed ID: 9789868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.
    Van Gerven F; Odds FC
    Mycoses; 1995; 38(9-10):389-93. PubMed ID: 8569815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal activity of amorolfine against Malassezia species].
    Uchida K; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1013-9. PubMed ID: 1960851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of Malassezia species using the urea broth microdilution method.
    Nakamura Y; Kano R; Murai T; Watanabe S; Hasegawa A
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2185-6. PubMed ID: 10898698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
    Rukayadi Y; Hwang JK
    Lett Appl Microbiol; 2007 Feb; 44(2):126-30. PubMed ID: 17257249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
    Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
    Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
    Far FE; Al-Obaidi MMJ; Desa MNM
    J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
    Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
    Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of systemic antifungal agents against Malassezia furfur.
    Marcon MJ; Durrell DE; Powell DA; Buesching WJ
    Antimicrob Agents Chemother; 1987 Jun; 31(6):951-3. PubMed ID: 3619430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Malassezia furfur against azole compounds.
    Schmidt A; Rühl-Hörster B
    Mycoses; 1996; 39(7-8):309-12. PubMed ID: 9009652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of climbazole, clotrimazole and silver-sulphadiazine against isolates of Malassezia pachydermatis.
    Schmidt A
    Zentralbl Veterinarmed B; 1997 Jun; 44(4):193-7. PubMed ID: 9230670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
    Zissova LG; Kantarjiev TB; Kuzmanov AH
    Folia Med (Plovdiv); 2001; 43(3):10-2. PubMed ID: 11930825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing of Malassezia pachydermatis using the urea broth microdilution method.
    Murai T; Nakamura Y; Kano R; Watanabe S; Hasegawa A
    Mycoses; 2002 Apr; 45(3-4):84-7. PubMed ID: 12000506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
    Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal activity of sertaconazole.
    Drouhet E; Dupont B
    Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
    Velegraki A; Alexopoulos EC; Kritikou S; Gaitanis G
    J Clin Microbiol; 2004 Aug; 42(8):3589-93. PubMed ID: 15297502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.
    Cafarchia C; Figueredo LA; Favuzzi V; Surico MR; Colao V; Iatta R; Montagna MT; Otranto D
    Vet Microbiol; 2012 Oct; 159(3-4):536-40. PubMed ID: 22622336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Malassezia furfur.
    Schmidt A; Rühl-Hörster B
    Arzneimittelforschung; 1996 Apr; 46(4):442-4. PubMed ID: 8740097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of newly synthesised fenporpimorph derivatives on some pathogen yeasts.
    Breierová E; Sajbidor J; Lamacka M
    Z Naturforsch C J Biosci; 2001; 56(1-2):53-7. PubMed ID: 11302214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.